Biotech Startups

Beeline Medicines is a biopharmaceutical company developing medicines for patients with serious diseases. The company is led by experienced healthcare and life sciences executives.

1 investor

Beijing Beilu manufactures contrast media, oral anti-diabetic medications, and traditional Chinese medicine for anxiety. The company operates a pharmaceutical production facility in Beijing's Miyun District with specialized workshops for injection products and quality control.

1 investor

Beken Bio develops nanobiology technology combined with machine learning for early cancer detection by targeting abundant biomarkers. The company serves the medical field and cancer prevention sector.

1 investor

Belenos Biosciences develops long-acting bispecific antibody therapeutics for chronic inflammatory diseases such as COPD, asthma, atopic dermatitis, CRSwNP, and CSU. Its pipeline includes BEL512 (targeting TSLP and IL-13) and BEL536 (targeting OX40L and IL-13), both aimed at modulating type 2 inflammation.

1 investor

BeLiver develops AI-powered tools that analyze biological data to support personalized cancer treatment decisions, beginning with liver cancer. The company combines advanced proteomics and machine learning to provide treatment predictions for clinicians and researchers.

1 investor

BellBrook Labs supplies life-science research products and services to laboratories, distributed internationally through regional partners across Europe, Asia, and Oceania. Its offerings serve the biotechnology and drug-discovery research market.

1 investor

1 investor

1 investor

BMK Genetics develops breeding programs and genetic solutions for salmon farming, offering tailored genetics for both sea-based open net-pen systems and land-based recirculating aquaculture systems. The company supplies ova and breeding stock optimized for disease resistance, growth, and environmental conditions specific to each farming method.

1 investor

Bened Biomedical develops probiotic products focused on neurological health, serving customers across more than 40 markets worldwide through regionally located manufacturing partners.

1 investor

Bertis is a proteomics company that uses AI-driven protein analysis, spatial biology, and its DEEP-find protein search engine to discover cancer therapeutic targets and biomarkers. It also markets proteomics-based early cancer diagnostic blood tests such as MASTOCHECK for breast cancer, serving pharmaceutical and precision-medicine research applications.

1 investor

Beryllium was a drug discovery contract research organization acquired by UCB Pharma in 2017.

1 investor

Best for Bees develops ProtectaBEE, an adjustable hive entrance device that allows beekeepers to introduce therapeutic powders and treatments into beehives to manage pests like Varroa mites and diseases such as foulbrood. The company, founded by Dr. Erica Shelley in partnership with University of Guelph researchers, serves commercial and hobbyist beekeepers seeking to improve hive health.

1 investor

Bexion Pharmaceuticals is a clinical-stage biopharmaceutical company developing biologic cancer therapies that target dysregulated sphingolipid metabolism to counter tumor survival and treatment resistance. Its lead program, BXQ-350, is being studied in patients with advanced solid tumors, including metastatic colorectal cancer.

1 investor

Beyond Next Ventures is a venture capital firm that partners with entrepreneurs and innovators to disrupt industries and create positive global impact.

1 investor

Bifido is a South Korean microbiome company that researches and develops Bifidobacterium strains and pharmabiotics — human microbiome-derived materials intended for the prevention or treatment of disease. It focuses on immune-related conditions such as rheumatoid arthritis and cancer, and produces probiotic strains including FDA-registered ingredients.

1 investor

Bikanta develops nanodiamond-based imaging probes for medical imaging and diagnostics, enabling background-free optical imaging aimed at disease detection such as cancer. Its technology targets researchers and medical professionals in the diagnostics field.

1 investor

Bilix develops BRIXELLE-ONCO, a bilirubin nanoparticle technology that serves as a non-toxic drug carrier for anti-cancer agents, designed to reduce side effects in cancer treatment by improving drug delivery to tumor sites. The technology uses naturally occurring bilirubin conjugated with PEG to encapsulate and deliver hydrophobic anti-cancer drugs with minimal systemic toxicity.

1 investor

Bind-X develops biological dust control technology for mining operations, using a natural bio-cementation process to bind soil particles and reduce dust on haul roads, tailings facilities, and stockpiles while significantly lowering water consumption and environmental impact.

1 investor

BIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.

1 investor

Bioplastix engineers E. coli and Halomonas bacteria using AI, enzyme optimization, and precision fermentation to produce high-performance PLA and PHB biopolymers from low-cost sugars and agroindustrial waste. It acts as a technology partner for petrochemical companies, agribusinesses, and consumer goods manufacturers, providing custom microbial strains, biopolymer formulations, and bioprocesses for bioplastic production.

1 investor

Distributor of scientific instrumentation and laboratory consumables serving food and beverage manufacturers, production, and materials science customers across Australia and New Zealand. Offers equipment and services for physical and chemical characterisation, life science, sample preparation, and general lab needs.

1 investor

Bio X Cell manufactures and supplies antibodies for in vivo, preclinical, translational, and functional research studies, offering citation lists and curated references to help scientists select products. It also provides antibody customization and high-volume production services, with distribution hubs in Europe and dedicated service for customers in China.

1 investor

Bio-Gate AG develops antimicrobial coatings and materials, including silver-based technology, applied to medical implants, veterinary care products, and other applications. The company serves the medical technology and animal-care markets, with activities in Germany and North America.

1 investor